Molecular Diagnostics Market Size

Report ID: GMI434
   |
Published Date: April 2023
 | 
Report Format: PDF

Download Free PDF

Molecular Diagnostics Market Size

Molecular Diagnostics Market size was worth USD 25 billion in 2022 and is projected to record more than 3.5% CAGR from 2023-2032. Increasing awareness regarding early disease diagnostics will accelerate industry growth.

 

Molecular Diagnostics Market

The market for point of care molecular diagnostics is likely to surpass USD 90 billion by 2032. Growing awareness regarding early disease diagnosis and advancements in automated technologies are expected to positively influence market outlook. New-generation diagnostic solutions are offering superior levels of accuracy, convenience of use, and portability enabling early detection of an array of infectious diseases. With the rising prevalence of infectious diseases and chronic illnesses such as cancer, molecular diagnosis has emerged as a vital tool in disease management and therapy. Furthermore, the growing emphasis on precision medicine is encouraging manufacturers to design high-performance testing solutions.

 

Authors: Mariam Faizullabhoy ,
Frequently Asked Question(FAQ) :
Which companies specialize in molecular diagnostics?
Biocartis, bioMerieux SA., Hologic Inc, Illumina, Inc, Qiagen, Siemens Healthineers, and Sysmex Corporation are some of the leading players in the market.
What factors are propelling North America molecular diagnostics industry size?
Why is the demand for molecular diagnostics growing in hospitals & clinics?
What is the molecular diagnostics market worth?
Related Reports
    Authors: Mariam Faizullabhoy ,
    Buy Now
    $4,123 $4,850
    15% off
    $4,840 $6,050
    20% off
    $5,845 $8,350
    30% off
        Buy now
    Premium Report Details

    Base Year: 2022

    Companies covered: 15

    Tables & Figures: 445

    Countries covered: 33

    Pages: 263

    Download Free PDF

    Top